PrEP and kidney function: who really needs screening and can event-based dosing reduce side-effects?
No breakthrough HIV infections seen in women using injectable PrEP
Better adherence to PrEP is associated with more bone loss
Top 5 stories on HIV prevention from CROI 2022
Injected PrEP: breakthrough cases could have been detected sooner
Injected PrEP: cabotegravir maintains its advantage over four years
PrEP for women in Europe webinars: evaluation form
For long-term PrEP, we need better definitions of adherence, conference hears
First efficacy results from England's PrEP IMPACT Trial
